Drug Trial Radar · NCT01353976
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis
Last checked: Nov 19, 2026Latest source record: Jan 9, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
264
Actual
Start
May 2011
Primary completion
Apr 2012
Study completion Aug 2012
Sponsor
- Lead sponsor
- AmDermaIndustry
- Sponsor type
- Industry
- Collaborators
- AmDerma Pharmaceuticals, LLC
- First posted
- May 16, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.
Conditions
- Tinea Pedis
- Athlete's Foot
Interventions
Econazole Nitrate Foam 1%Drug
Econazole Nitrate Foam 1% applied once a day for 4 weeks
Vehicle FoamOther
Vehicle foam applied once a day for 4 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete CureTime frame: Day 43
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Francisco Flores, MD
Miramar, Florida
Daniel M. Stewart, DO
Clinton Township, Michigan
Cyaandi Dove, DPM
Las Vegas, Nevada
Robert S. Haber, MD
South Euclid, Ohio
Cynthia Strout, MD
Mt. Pleasant, South Carolina
Michael H. Gold, MD
Nashville, Tennessee
Jeffrey Adelglass, MD
Plano, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.